Apoptosis is critical for mammalian tissue homeostasis, and its disruption has been linked to a wide variety of disorders, including cancer, neurodegenerative disease, autoimmune disease and diabetes. This review will focus on recent investigations that have begun to address the potential role of apoptosis in adipose tissue growth. Evidence for apoptosis occurring in mature adipocytes has been obtained through the use of in vitro cell culture models as well as in vivo studies in rodents and humans. Preadipocytes, ®broblast-like adipocyte precursor cells, can also undergo apoptotic cell death. As they differentiate, preadipocytes acquire a relative resistance to apoptosis. The levels of the cell survival proteins Bcl-2 and neuronal apoptosis inhibitory protein (NAIP) have been observed to increase during adipogenesis. Further research on the effect of apoptosis on adipose tissue cellularity should clarify its in¯uence on adipose tissue mass and distribution.
Introduction
The prevalence of obesity is rising in a global fashion, placing this population at higher risk for type 2 diabetes mellitus and cardiovascular disease. 1 Current strategies for treatment of obesity are largely unsuccessful over the long term, since weight loss, even when achieved initially, is often followed by weight regain. 2 More knowledge about the molecular and cellular mechanisms governing adipose tissue accumulation is needed to develop more effective preventative and therapeutic approaches to obesity.
Obesity is characterized by an increase in adipocyte number and size. Adipose tissue cellularity is linked to the dynamic role played by preadipocytes. Preadipocytes, which reside in the adipose tissue stromal ± vascular compartment, are specialized ®broblast-like progenitor cells which proceed through a complex program of gene expression to differentiate into terminal mature adipocytes when appropriately cued. 3, 4 The cell population can be controlled via proliferation and differentiation of preadipocytes into adipocytes, and, possibly, through de-differentiation of adipocytes into preadipocytes. The complex destiny of preadipocytes makes them an attractive target for novel molecular strategies aimed at curtailing excess adipose tissue accumulation. Studies that will be reviewed here suggest that apoptosis of adipose cells, both preadipocytes and adipocytes, is another route by which to regulate adipose tissue mass (this brief review will not discuss brown adipose tissue).
Adipose tissue growth: cell number and cell size As depicted in Figure 1 , excess energy (intake b expenditure) is directed to white adipose tissue for storage as triacylglycerol (lipogenesis). The capacity for adipose tissue to store signi®cant amounts of energy depends on the creation of new adipocytes. 5, 6 Paracrine factors released by enlarged adipocytes may induce neighbouring preadipocytes to grow and differentiate, bolstering the adipose tissue energy reservoir. 7 ± 11 An activating mutation in a key adipogenic regulator (PPARg; see below) associated with human obesity, highlighting the importance of new fat cell formation in adipose tissue growth. 12 Energy de®cit stimulates free fatty acid release from adipocytes (lipolysis), generating smaller adipocytes. 13, 14 Adipose tissue mass can also shrink due to loss of cells via apoptosis, a regulated cell death program.
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Apoptosis of preadipocytes and adipocytes
Apoptosis allows for complex developmental processes and ongoing homeostasis in many tissues and organ systems. 15 Morphologically, one observes cell shrinkage accompanied by chromatin condensation. This is followed by membrane blebbing and the budding of apoptotic bodies containing organelles andaor condensed chromatin. Biochemically, apoptosis is characterized by the activation of cysteine proteases directed to cleave proteins after aspartic acid residues, known as caspases. Caspase action on their`death' substrates leads to cell death in a number of ways, such as via the digestion of genomic DNA into oligonucleosomal fragments (laddering). Other cytotoxic events include reorganization of the cytoskeleton and the disassembly of cell structures.
Deletion of white adipose tissue cells, assessed by DNA content, was ®rst reported in rodent models of catabolic stress, including starvation and uncontrolled streptozotocin-induced diabetes mellitus (reviewed in Prins and O'Rahilly 16 ). A more recent study on rodents treated for 4 days with intra-cerebroventricular leptin described decreases in fat pad DNA content and weight, as well as apoptotic features in adipose tissue samples. 17 These included DNA laddering and TUNEL (TdT-mediated dUTP nick end labeling) staining. Pair-fed rats showed smaller decreases in fat pad weight, and no change in DNA content. Subcutaneous leptin treatment for 2 weeks in mice also resulted in profound decreases in fat pad weight, but without apoptosis or necrosis. 18 In another model of leptin exposure, rats overproducing leptin (due to hepatic overexpression following adenoviral gene transfer) developed tremendous decreases in fat pad weight, but no change in DNA content was observed. 19 In 1994, human adipose tissue explants were ®rst reported to exhibit features of apoptosis after growth factor deprivation and heat injury. 20 Ultrastructural changes visualized with electron microscopy were observed in cells within sections of the adipose tissue explants. Extracted DNA from the treated explants showed oligonucleosomal DNA laddering. Adipose tissue explants from cancer patients 21 were also studied, and similar ®ndings were described.
Tumor necrosis factor a (TNFa) was found to induce apoptotic death when added to human adipose tissue explants, as assessed by the same strategies. 22 For all these studies, 20 ± 22 the precise identity of the cells (believed to be adipocytes) within the tissue section exhibiting the apoptotic features under electron microscopy is not entirely clear. To date, there have been no reports on apoptosis in cultured human adipocytes.
Human preadipocytes isolated from adipose tissue were cultured and also shown to undergo apoptosis in response to TNFa. Differences in the sensitivity to TNFa between the cultured preadipocytes and the adipose tissue explants might have arisen due to technical differences in the assays used to measure apoptosis. 22 The apoptotic response of human preadipocytes appears to be in¯uenced by anatomic region. Intra-abdominal omental preadipocytes in culture were more likely to undergo apoptosis in response to serum-starvation or TNFa treatment than those obtained from the abdominal subcutaneous depot. 23 Regional fat deposition may be regulated, in part, by apoptosis of preadipocytes.
Interestingly, TNFa has also been shown to prevent the maturation of human preadipocytes in culture, and to induce delipidation of newly differentiated adipocytes. 24 Glycerol phosphate dehydrogenase activity, a marker of late-phase differentiation, was also decreased. Other adipogenic markers were not assessed to evaluate whether actual`de-differentiation' had occurred. Surprisingly, no cytotoxic effects of TNFa were observed. 
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The effect of adipogenesis on susceptibility to apoptosis
Recent data indicate that adipocyte differentiation in¯uences apoptotic susceptibility, suggesting that preadipocytes may be the relevant susceptible cells for future interventions to target adipose tissue apoptosis. An earlier study had demonstrated that when 3T3-L1 preadipocytes were cultured in medium supplemented with delipidated serum, treatment with retinoic acid and 9-cis-retinoic acid triggered apoptosis. 25 The studies on adipogenesis and susceptibility to apoptosis employed the 3T3-L1 and 3T3-F442A cell line models of adipocyte differentiation.
4 3T3-L1 preadipocytes underwent apoptosis when subjected to growth factor withdrawal, as assessed by Hoescht staining, DNA fragmentation and TUNEL. 26 However, after differentiation, they developed a marked resistance to apoptosis induced by growth factor deprivation. To begin to understand the basis for this differentiation-dependent effect on apoptotic resistance, the levels of Bcl-2 protein were analyzed. There was a signi®cant increase in Bcl-2 protein expression during differentiation, suggesting a possible role for this pro-survival factor in the acquisition of apoptotic resistance in these cells. Bcl-2 belongs to a growing family of proteins which contain both antiand pro-apoptotic members (reviewed in Raff 15 ). As shown in Figure 2 , in the presence of growth factor, activation of the phosphoinositide 3-kinaseaprotein kinase B pathway leads to the phosphorylation of Bad. Phosphorylated Bad does not associate with Bcl-2, thereby allowing Bcl-2 action to retain cytochrome c within the mitochondria. In the absence of growth factor, Bad is no longer phosphorylated and heterodimerized with Bcl-2, which permits cytochrome c to be released, triggering the caspase cascade. 15 A large decrease in the protein levels of DNase I was also observed with adipogenesis. This enzyme has been implicated in apoptotic DNA cleavage in other systems; its downregulation during differentiation is consistent with the enhanced survival of the differentiated adipocytes.
A new family of mammalian inhibitors of apoptosis (IAP) have been identi®ed, the ®rst of which was neuronal apoptosis inhibitor protein (NAIP). NAIP was found through a positional cloning strategy to determine the candidate gene causing spinal muscle atrophy, a neurodegenerative disease. 27 Members of this family contain the baculovirus IAP repeat (BIR) domain, a region of about 70 amino acids involved in Figure 2 Potential survival and apoptotic pathways in the adipocyte. The survivalagrowth factor receptor activates phosphoinositide 3-kinase (PI3K) resulting in the phosphorylation of PI(4,5)P2 into PI(3,4,5) P3 and PI (3, 4) P2. This activates the phosphoinositidedependent kinases (PDKs) and protein kinase B (PKB), also known as Akt. PKB prevents apoptosis by phosphorylating (and inactivating) caspase 9 and Bad, allowing Bcl-2 to keep cytochrome c (cyto c) in the mitochondrion. Upon growth factor deprivation, caspase 9 is released from its inhibition by PKB. In addition, Bad interferes with Bcl-2 function, allowing cyto C to enter the cytosol, interact with Apaf-1 (apoptosis protease activating factor-1), and activate caspase 9. Caspase 9 then initiates a caspase cascade leading to apoptosis. NAIP inhibits caspase-3 (and caspase-7 Ð not shown). TNFa can act on its receptor, TNFR1, and may trigger apoptosis in the adipocyte through caspase 8 activation.
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The regulated expression of NAIP during adipogenesis has been investigated. 28 Low levels of expression occur in 3T3-L1 and 3T3-F442A preadipocytes, with a b 20 ± 50 fold induction in protein levels after differentiation. Control 3T3-C2 cells, which do not differentiate, showed no induction when treated with differentiation medium. Another IAP member, HIAP-2, was expressed at low levels and did not change throughout differentiation. NAIP was also expressed in mature rat adipocytes, and has also been shown to increase during differentiation of human preadipocytes in primary culture. 29 Both Bcl-2 and NAIP may therefore in¯uence adipocyte survival, but a causal role has yet to be established.
Other evidence for a potential role for NAIP in adipose tissue was seen in a study examining humanpreadipocyte protein expression pro®le before and after weight loss. 30 Preadipocytes isolated from subcutaneous abdominal fat biopsies obtained from patients before and after (4 months later) successful weight reduction were placed in primary culture, grown to con¯uence, and solubilized protein was then electrophoresed and subjected to immunoblot analysis. The data indicate that after weight loss ( 17% of initial weight, n 6), there are 3 ± 5-fold higher levels of NAIP in preadipocytes. These preadipocytes may also be somewhat farther along the continuum of differentiation, since they also express more CaEBPa (although PPARg levels remained unchanged). This suggests that these preadipocytes, although morphologically unchanged, may be more resistant to apoptosis, favouring weight regain over time. The route by which weight loss might regulate preadipocyte gene expression is unknown, but might include decreases in relevant adipo' cytokines, such as leptin and TNFa andaor an increase in insulin sensitivity.
Conclusions
Evidence of apoptosis in adipose tissue is accumulating. More work is needed to demonstrate the precise identity of the cells targeted, as well as to examine the situations during which apoptosis may occur in vivo. Our understanding of the molecular stimuli inducing apoptosis is also quite rudimentary at present, as is the possibility of regional anatomic site-speci®city. Future work in this area is expected to dovetail with the emerging view of adipose tissue as a site of dynamic complexity, with sophisticated processes governing the interactions of preadipocytes and adipocytes.
